Cargando…
Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
The pathogenic hyper-inflammatory response has been revealed as the major cause of the severity and death of the Corona Virus Disease 2019 (COVID-19). Xuanfei Baidu Decoction (XFBD) as one of the “three medicines and three prescriptions” for the clinically effective treatment of COVID-19 in China, s...
Autores principales: | Wang, Yuying, Wang, Xi, Li, Yixuan, Xue, Zhifeng, Shao, Rui, Li, Lin, Zhu, Yan, Zhang, Han, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757644/ https://www.ncbi.nlm.nih.gov/pubmed/35033647 http://dx.doi.org/10.1016/j.phrs.2022.106083 |
Ejemplares similares
-
Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
por: Wang, Yuying, et al.
Publicado: (2022) -
Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2021) -
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2022) -
Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms
por: Meng, Tiantian, et al.
Publicado: (2023) -
Xuanfei Baidu Decoction regulates NETs formation via CXCL2/CXCR2 signaling pathway that is involved in acute lung injury
por: Zhou, Mengen, et al.
Publicado: (2023)